Corona Remedies surges up to 41% on debut underscoring local demand for new stocks

Corona Remedies share price rose as much as 41.14% over the IPO price of ₹1,062 to an intraday high of ₹1,499 apiece, after listing at 36.72% premium.

Updated on: Dec 15, 2025, 11:47:07 IST

By HT Business Desk

Prefer HTon Google

Share via

Copy link

Drugmaker Corona Remedies Ltd. debuted at a premium on the stock market today, underscoring demand for new stocks among domestic investors.

A 40% surge in Corona Remedies' share price gave the company a market capitalisation of nearly ₹9,000 crore. (HT)

After listing at 36.72% premium, Corona Remedies share price rose as much as 41.14% over the IPO price of ₹1,062 to an intraday high of ₹1,499 apiece on the BSE, according to stock market data. That gave the company a market capitalisation of nearly ₹9,000 crore.

Headquartered in Ahmedabad, Gujarat, Corona Remedies is a pharmaceutical formulation company focused on women's healthcare. Its 8-10 December ₹650 crore IPO had received 137.04 times subscription.

ABOUT THE AUTHOR
HT Business Desk
The HT Business Desk provides comprehensive coverage of the Indian and global financial markets. Based in Mumbai and New Delhi, the team tracks everything from Sensex and Nifty movements to the latest from India Inc., trade deals, and macroeconomic policy. We aim to empower readers with timely, fact-checked news that clarifies the complexities of the business world.Read More

Stay updated with the latest Business News, stock market updates, petrol and diesel prices, gold and silver rates, income tax updates and major developments from India and across the world.